Europe Home Infusion Therapy Market Outlook Product, Application, Countries and Forecast 2026-2034

Europe Home Infusion Therapy Market Trends

Europe Home Infusion Therapy Market is projected to grow from US$ 13.84 Billion in 2025 to US$ 23.13 Billion by 2034, registering a CAGR of 5.87% during 2026–2034. Market growth is driven by the increasing prevalence of chronic diseases, rising preference for home-based healthcare, and an expanding elderly population. Technological advancements in portable infusion devices, favorable reimbursement policies, and growing demand for cost-effective treatment outside hospitals are further accelerating adoption, supporting sustained market expansion across Europe.

Europe Home Infusion Therapy Market Outlooks

Home infusion therapy is a healthcare service that enables patients to receive intravenous (IV) medications, fluids, nutrition, or specialty biologic therapies safely in their homes instead of hospitals or outpatient clinics. The treatment is administered using infusion pumps, catheters, and vascular access devices under the supervision of trained healthcare professionals or through patient and caregiver education. Home infusion therapy is commonly used for administering antibiotics, chemotherapy, immunoglobulin therapy, parenteral nutrition, hydration therapy, pain management medications, biologics, and treatments for chronic diseases such as cancer, autoimmune disorders, gastrointestinal diseases, and severe infections. The approach improves patient comfort while reducing hospital stays and healthcare costs.

In Europe, home infusion therapy has gained significant popularity due to the increasing prevalence of chronic diseases, an aging population, and growing pressure to reduce hospital admissions. Many European healthcare systems encourage home-based care as a cost-effective alternative that enhances patient satisfaction and minimizes the risk of hospital-acquired infections. Advances in portable infusion pumps, remote patient monitoring, telehealth services, and user-friendly infusion devices have further supported adoption. Expanding reimbursement policies, improved home healthcare infrastructure, and increasing awareness among healthcare providers and patients continue to drive the widespread use of home infusion therapy across hospitals, specialty clinics, and home healthcare settings throughout Europe.

Key Highlights - Increase in the Share of the Population Aged 65 Years and Over Between 2015 and 2025

• European Union (EU): The proportion of people aged 65 years and over increased by approximately 2.9 percentage points between 2015 and 2025.
• Albania (AL) recorded the highest increase, at approximately 8.8 percentage points.
• North Macedonia (MK) experienced the second-largest increase, at around 5.9 percentage points.
• Poland (PL) recorded an increase of approximately 5.6 percentage points.
• Norway (NO) showed a significant rise of approximately 4.7 percentage points.
• Slovakia (SK) experienced an increase of about 4.8 percentage points.
• Croatia (HR) and Serbia (RS) recorded increases of approximately 4.2–4.3 percentage points.
• Slovenia (SI) saw an increase of around 4.1 percentage points.
• Portugal (PT) recorded an increase of approximately 3.9 percentage points.
• Cyprus (CY) experienced an increase of around 3.8 percentage points.
• Finland (FI) and France (FR) each registered increases of approximately 3.6–3.7 percentage points.
• Bulgaria (BG) recorded an increase of about 3.5 percentage points.
• Romania (RO) experienced an increase of approximately 3.3 percentage points.
• Hungary (HU) recorded an increase of around 3.1 percentage points.
• Netherlands (NL) and Czechia (CZ) each saw increases of approximately 3.0 percentage points.
• Ireland (IE), Estonia (EE), and Lithuania (LT) experienced increases of approximately 2.8 percentage points.
• Latvia (LV) recorded an increase of around 2.5 percentage points.
• Denmark (DK), Iceland (IS), Spain (ES), and Switzerland (CH) experienced increases ranging from 2.3 to 2.4 percentage points.
• Belgium (BE) and Austria (AT) recorded increases of approximately 2.1 percentage points.
• Germany (DE) showed an increase of around 1.7 percentage points.
• Sweden (SE) experienced an increase of approximately 1.2 percentage points.
• Luxembourg (LU) recorded an increase of about 1.0 percentage point.
• Malta (MT) had the smallest increase, at approximately 0.4 percentage points.
• Montenegro (ME) recorded an increase of approximately 3.5 percentage points.
• Georgia (GE) experienced an increase of around 2.7 percentage points.
• Türkiye (TR) recorded an increase of approximately 2.6 percentage points.
• Overall Trend: The chart highlights a steady aging of Europe’s population, with nearly all countries experiencing an increase in the proportion of residents aged 65 years and above, reinforcing demand for healthcare services, long-term care, home healthcare, chronic disease management, and age-related medical technologies.

Growth Driver

Increasing Demand for Long-Term Home-Based Treatment

The growing burden of chronic diseases is a major driver of the Europe Home Infusion Therapy Market. Europe has one of the world’s oldest populations, with more than 21% of the EU population aged 65 years and above, and this proportion continues to increase. Chronic illnesses such as cancer, diabetes, autoimmune disorders, inflammatory bowel disease, heart failure, and neurological conditions frequently require prolonged intravenous therapies that can safely be administered at home. More than 60 million adults in Europe live with diabetes, while cardiovascular diseases account for approximately 1.7 million deaths annually in the European Union, creating sustained demand for long-term infusion treatments. Home infusion therapy enables patients to receive antibiotics, biologics, immunoglobulins, hydration therapy, and parenteral nutrition without extended hospitalization. This approach improves quality of life, reduces hospital congestion, and lowers the risk of healthcare-associated infections. As the elderly population and chronic disease prevalence continue to grow, healthcare providers are increasingly integrating home infusion services into routine disease management, supporting strong market expansion throughout Europe.

Shift from Hospital-Centered Care to Home-Based Services

European healthcare systems are increasingly promoting home-based healthcare to improve patient outcomes while reducing healthcare expenditure. Hospital admissions and inpatient care represent a significant portion of healthcare spending, encouraging governments and insurers to support alternative treatment models. Home infusion therapy has emerged as a cost-effective solution for administering intravenous medications outside hospitals while maintaining clinical effectiveness. Several European countries have expanded reimbursement frameworks for home nursing, infusion therapy, and remote patient monitoring, encouraging wider adoption among healthcare providers. The increasing number of specialized home healthcare agencies and community nursing services has further strengthened service availability across Western Europe. Home infusion therapy also reduces hospital bed occupancy and enables earlier patient discharge following surgery or acute illness. Growing investments in integrated healthcare systems, digital health technologies, and coordinated outpatient care continue accelerating market development. As healthcare providers prioritize value-based care and patient-centered treatment models, demand for home infusion therapy services is expected to increase steadily across hospitals, specialty clinics, and home healthcare organizations throughout Europe.

Portable Infusion Pumps and Remote Patient Monitoring Improving Adoption

Technological innovation has significantly strengthened the Europe Home Infusion Therapy Market by making intravenous treatment safer, more convenient, and easier to monitor outside traditional healthcare settings. Modern portable infusion pumps, programmable electronic devices, elastomeric pumps, and wearable infusion systems enable accurate drug delivery while allowing patients greater mobility during treatment. Europe continues to experience rapid digital health adoption, with internet penetration exceeding 90% in many Western European countries, supporting broader implementation of telemedicine and remote patient monitoring. Healthcare professionals can now track infusion progress, medication adherence, and patient safety through connected digital platforms, reducing unnecessary hospital visits. Smart infusion pumps equipped with dose-error reduction software improve medication accuracy and minimize administration risks. Continuous improvements in catheter technologies, disposable infusion sets, and wireless monitoring systems further enhance patient safety and treatment efficiency. These innovations increase physician confidence in home-based therapy while improving patient convenience. Ongoing investment in connected healthcare technologies and digital infrastructure is expected to accelerate adoption of advanced home infusion therapy services throughout Europe.

Home Infusion Therapy Launches in Europe

• Baxter – Novum IQ Large Volume Infusion Pump (2025) – Expanded European launch of the next-generation smart infusion pump with advanced dose-error reduction software and interoperability features for hospital and home infusion settings.
• B. Braun – Spaceplus Infusion Pump System (2025) – Introduced across additional European markets with improved wireless connectivity, enhanced user interface, and remote monitoring capabilities for home and ambulatory infusion therapy.
• Fresenius Kabi – Agilia Connect Infusion System (2024) – Expanded the European rollout of connected infusion pumps supporting safer home administration of intravenous medications and biologic therapies.
• ICU Medical – Plum Solo™ Precision Infusion Pump (2025) – Launched in selected European countries as a lightweight ambulatory infusion system designed for home infusion, oncology, and anti-infective therapies.
• Micrel Medical Devices – Rythmic™ Evolution Blue Infusion Pump (2024) – Introduced an upgraded portable infusion pump featuring Bluetooth connectivity and enhanced programming for home-based intravenous therapy.
• Eitan Medical – Sapphire™ Infusion Platform Update (2025) – Expanded its European home healthcare portfolio with upgraded software supporting remote monitoring, medication safety, and ambulatory infusion services.
• Fresenius Kabi – Kabiven® Peripheral Three-Chamber Parenteral Nutrition Bag (2024) – Expanded European availability for home parenteral nutrition patients requiring long-term intravenous nutritional support.
• Baxter – SIGMA Spectrum Infusion System European Software Upgrade (2025) – Released enhanced cybersecurity, smart pump functionality, and wireless integration for home infusion and outpatient care environments.
• B. Braun – Easypump® ST/LT Elastomeric Infusion Pump Expansion (2024) – Expanded availability across Europe for home administration of antibiotics, chemotherapy, pain management, and palliative care therapies.
• Smiths Medical – CADD®-Solis Ambulatory Infusion Pump Software Enhancement (2025) – Introduced updated drug libraries, improved dose safety features, and enhanced outpatient compatibility for long-term home infusion therapy across European healthcare providers.

Challenge

Limited Availability of Specialized Nursing Services

A significant challenge facing the Europe Home Infusion Therapy Market is the shortage of qualified healthcare professionals trained in home infusion services. Successful home infusion therapy requires experienced nurses capable of managing vascular access devices, administering intravenous medications, educating patients, and responding to potential complications. Many European countries continue to experience workforce shortages due to aging healthcare professionals, increasing patient demand, and recruitment challenges. Rural and remote regions are particularly affected by limited availability of specialized home healthcare providers, resulting in unequal access to infusion services. In addition, growing demand for chronic disease management places further pressure on existing nursing resources. Training requirements for handling biologics, chemotherapy, parenteral nutrition, and immunoglobulin therapies increase operational complexity for healthcare organizations. Healthcare providers must also invest in continuous professional education to maintain quality standards and patient safety. Without sufficient skilled personnel, expanding home infusion programs becomes difficult, potentially slowing market growth despite increasing patient demand across Europe.

Uneven Healthcare Policies Affecting Market Expansion

Differences in reimbursement systems and healthcare regulations across European countries remain a major obstacle for the Home Infusion Therapy Market. While several Western European nations provide comprehensive reimbursement for home-based infusion services, coverage varies considerably across Central and Eastern Europe. Differences in national healthcare budgets, insurance policies, and clinical practice guidelines create inconsistent patient access to advanced infusion therapies. Medical device approvals, pharmaceutical regulations, and home healthcare standards also differ among countries, increasing administrative complexity for manufacturers and service providers. Companies operating across multiple European markets must comply with diverse regulatory requirements relating to infusion pumps, biologic medications, patient monitoring, and home nursing services. These regulatory differences increase operational costs, delay market entry, and complicate cross-border expansion. Furthermore, reimbursement limitations may discourage hospitals and healthcare providers from adopting advanced home infusion programs despite their long-term economic benefits. Harmonization of healthcare policies and broader reimbursement support will be essential for achieving more consistent market growth across Europe.

Portable Infusion Technologies Driving Home-Based Healthcare

Europe Home Infusion Pump Market is witnessing strong growth as healthcare systems increasingly shift from hospital-based treatment to home care for chronic disease management. Home infusion pumps provide accurate and continuous delivery of medications, parenteral nutrition, chemotherapy, hydration, and biologic therapies while enabling patients to remain in their homes. Europe has more than 100 million people living with at least one chronic disease, creating sustained demand for long-term infusion therapies. Additionally, over 21% of the European Union population is aged 65 years or older, increasing the need for portable and user-friendly infusion devices. Technological innovations such as programmable smart pumps, ambulatory infusion systems, elastomeric pumps, wireless monitoring, and dose-error reduction software have significantly improved treatment safety and patient compliance. Healthcare providers increasingly prefer portable pumps because they reduce hospitalization, lower healthcare expenditure, and improve patient quality of life. Growing telehealth adoption and remote patient monitoring further support home infusion pump utilization. Continuous investment in digital healthcare technologies is expected to accelerate market expansion across hospitals, home healthcare agencies, and specialty care providers throughout Europe.

Increasing Demand for Safe and Reliable IV Administration Systems

Europe Home Infusion Intravenous (IV) Sets Market is expanding steadily due to rising utilization of home-based intravenous therapies for chronic diseases, infectious conditions, and nutritional support. Intravenous administration sets are essential components of home infusion systems, ensuring safe delivery of medications, fluids, antibiotics, chemotherapy, and biologics. Europe performs millions of intravenous therapy procedures annually, with an increasing proportion transitioning from hospitals to home healthcare settings. The growing prevalence of cancer, autoimmune diseases, gastrointestinal disorders, and severe infections has increased demand for reliable disposable IV tubing, connectors, filters, and administration accessories. Healthcare providers are emphasizing infection prevention through sterile, single-use IV administration systems that minimize catheter-related complications. Advancements including needle-free connectors, anti-free-flow mechanisms, precision flow regulators, and antimicrobial materials have improved patient safety during long-term therapy. Increasing regulatory emphasis on infection control, combined with expanding home healthcare services and rising patient preference for home treatment, continues to drive consistent demand for advanced intravenous administration sets throughout Europe.

Growing Need for Long-Term Nutritional Support Outside Hospitals

Europe Parenteral Nutrition Home Infusion Therapy Market is experiencing sustained growth as increasing numbers of patients require long-term nutritional support for gastrointestinal disorders and complex medical conditions. Home parenteral nutrition (HPN) provides intravenous delivery of essential nutrients when the digestive system cannot adequately absorb food. Conditions such as short bowel syndrome, Crohn’s disease, intestinal failure, gastrointestinal cancers, and severe malabsorption syndromes have increased demand for long-term nutritional therapy. Europe has established specialized intestinal failure centers and multidisciplinary nutrition teams that support safe home administration of parenteral nutrition. Portable infusion pumps, customized nutrient formulations, and improved catheter technologies have enhanced patient safety while allowing individuals to maintain normal daily activities. Expanding home healthcare infrastructure and specialized nursing services further facilitate long-term nutritional management outside hospitals. Growing awareness of quality-of-life benefits, reduced hospitalization, and improved clinical outcomes has strengthened physician confidence in home parenteral nutrition. Continuous improvements in sterile compounding techniques and patient monitoring are expected to support further market expansion across Europe.

Expanding Outpatient Intravenous Antibiotic Treatment Programs

Europe Anti-Infective Home Infusion Therapy Market is growing rapidly as healthcare systems increasingly adopt outpatient parenteral antimicrobial therapy (OPAT) programs. Home infusion enables patients with severe bacterial infections to receive intravenous antibiotics without prolonged hospitalization, reducing healthcare costs and improving patient convenience. Europe records millions of hospital admissions annually due to infectious diseases, while antimicrobial stewardship initiatives encourage early hospital discharge with continued home-based treatment where clinically appropriate. Common indications include osteomyelitis, infective endocarditis, complicated urinary tract infections, skin and soft tissue infections, and respiratory infections. Portable elastomeric infusion pumps and programmable electronic pumps allow safe administration of antibiotics under nurse supervision or trained caregiver support. Advances in vascular access devices, catheter care, and remote monitoring have significantly improved treatment safety and adherence. Growing awareness of hospital-acquired infection prevention, combined with increasing healthcare system efficiency initiatives, continues to expand the adoption of anti-infective home infusion services across hospitals, infectious disease clinics, and community healthcare providers throughout Europe.

Increasing Adoption of Home-Based Cancer Treatment Services

Europe Chemotherapy Home Infusion Therapy Market is expanding as oncology care increasingly incorporates home-based treatment models for selected cancer patients. Europe reports approximately 2.7 million new cancer cases annually, creating substantial demand for long-term chemotherapy administration and supportive infusion therapies. Advances in portable infusion pumps, central venous access devices, and remote patient monitoring have enabled safe administration of certain chemotherapy regimens in home environments under strict clinical supervision. Home infusion reduces hospital visits, improves patient comfort, minimizes travel burden, and enhances overall quality of life, particularly for elderly and immunocompromised patients. Multidisciplinary oncology teams carefully select eligible patients based on treatment protocols and clinical stability to ensure safe home administration. Growing investments in home healthcare infrastructure, specialized oncology nursing services, and digital health technologies further support market growth. Increasing adoption of ambulatory chemotherapy, supportive biologic infusions, hydration therapy, and symptom management programs is expected to strengthen the role of home infusion therapy within Europe’s evolving cancer care landscape.

Expanding Home-Based Care Through NHS and Community Healthcare Services in United Kingdom

United Kingdom Home Infusion Therapy Market is experiencing steady growth as the National Health Service (NHS) increasingly promotes home-based treatment to improve patient outcomes and reduce hospital admissions. The UK has a population of approximately 69 million, with nearly 19% aged 65 years and above, contributing to rising demand for long-term infusion therapies for chronic diseases. Home infusion is widely used for intravenous antibiotics, immunoglobulin therapy, chemotherapy, biologics, hydration, and parenteral nutrition. The NHS has expanded outpatient and community healthcare programs to facilitate early hospital discharge and support treatment in patients’ homes. Technological advancements in portable infusion pumps, electronic monitoring systems, and telemedicine have enhanced treatment safety and patient compliance. Growing prevalence of cancer, autoimmune diseases, gastrointestinal disorders, and severe infections continues to increase the need for home infusion services. Strong collaboration between hospitals, community nursing teams, and home healthcare providers supports efficient therapy delivery while reducing healthcare costs. Continuous investment in digital health infrastructure is expected to sustain long-term market growth throughout the United Kingdom.

Germany Advanced Healthcare Infrastructure Supporting Long-Term Infusion Care

Germany Home Infusion Therapy Market represents one of Europe’s largest markets due to the country’s highly developed healthcare system and increasing adoption of outpatient treatment models. Germany has a population exceeding 84 million, with more than 22% of residents aged 65 years or older, creating substantial demand for chronic disease management. The country spends approximately 12% of its GDP on healthcare, supporting investment in advanced infusion technologies and home healthcare services. Home infusion therapy is increasingly utilized for chemotherapy, biologics, intravenous antibiotics, immunoglobulin replacement, and parenteral nutrition. German hospitals and specialized home healthcare providers are expanding integrated care pathways that allow patients to continue intravenous treatment safely after discharge. Smart infusion pumps, digital monitoring platforms, and electronic prescribing systems have improved treatment accuracy and patient adherence. Continuous innovation in medical devices, strong reimbursement mechanisms for selected home healthcare services, and increasing physician awareness continue driving adoption. Germany’s aging population and expanding chronic disease burden are expected to maintain robust market growth over the coming years.

Spain Growing Demand Driven by Aging Population and Healthcare Modernization

Spain Home Infusion Therapy Market is expanding steadily as healthcare providers increasingly shift chronic disease management from hospitals to patients’ homes. Spain has a population of approximately 49 million, with around 21% of the population aged 65 years and above, making it one of Europe’s oldest populations. Rising incidences of cancer, cardiovascular disease, autoimmune disorders, and gastrointestinal conditions have significantly increased demand for long-term infusion therapies. Home infusion services are widely used for intravenous antibiotics, nutritional support, oncology treatments, biologic medicines, and hydration therapy. Spanish healthcare authorities continue promoting integrated home care services to improve patient quality of life while reducing hospital occupancy and healthcare expenditure. Increasing availability of portable infusion pumps, elastomeric devices, remote monitoring technologies, and trained home nursing professionals has enhanced treatment accessibility. Growing investment in telemedicine and digital healthcare platforms further supports patient monitoring and therapy adherence. Continued modernization of healthcare infrastructure and expansion of community-based medical services are expected to strengthen Spain’s home infusion therapy market in the coming years.

France Strong Home Healthcare Network Accelerating Infusion Therapy Adoption

France Home Infusion Therapy Market is among the fastest-growing in Europe, supported by a well-established home healthcare system and increasing adoption of outpatient treatment services. France has a population of approximately 68 million, with nearly 21% of residents aged 65 years or older, contributing to rising demand for long-term intravenous therapies. Home infusion therapy is extensively used for chemotherapy, anti-infective treatment, immunoglobulin administration, biologic therapies, hydration, and home parenteral nutrition. France has developed one of Europe’s strongest home hospitalization and community healthcare networks, enabling patients to receive complex infusion treatments under professional medical supervision. Technological advancements in portable infusion pumps, vascular access devices, and digital patient monitoring have improved treatment safety while minimizing hospital visits. Increasing prevalence of chronic illnesses, favorable healthcare policies supporting home-based care, and expanding multidisciplinary care teams continue driving market growth. Ongoing investment in telehealth, connected medical devices, and integrated care pathways is expected to further strengthen the adoption of home infusion therapy across France.

Market Segmentation

Product

• Infusion Pump
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

Application

• Anti-Infective
• Hydration Therapy
• Chemotherapy
• Enternal Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

Country

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Pfizer Inc.
• Smith & Nephew plc
• Terumo Corporation
• Johnson & Johnson Services, Inc.
• Becton, Dickinson and Company
• Baxter International Inc.
• ICU Medical
• Eli Lilly and Company

Report Details: